Top Dividend Stocks to Buy in October
What's the one thing that could put GM's 30-million plus auto recalls cleanly in the rearview mirror? How about a scandal involving Volkswagen .
Sometimes one company's pain is the gain of another. In this instance the loss of consumer trust stemming from Volkswagen's stunning admission that it "cheated" on diesel engine emissions tests by using software designed to subvert the tests could be just enough for shareholders to hit the gas on GM again. It's also worth noting that bad PR in the auto industry rarely lasts more than a few quarters, so GM's brand image with consumers was likely due to stabilize in the near-term anyway.
Beyond just benefiting from Volkswagen's miscues, GM has other factors working in its favor. After waiting more than a half decade to redesign its GMC Sierra and Chevrolet Silverado, the 2014 debuts of both vehicles have led to a surge in sales. After tallying 480,414 Silverados sold in the U.S. in 2013, and 184,389 Sierras, the Silverado looks to be on pace to eclipse 550,000 sales in 2015, and the Sierra could make a run at 225,000 vehicles. Updated aesthetics, improved durability, and better fuel mileage are key reasons why GM's trucks are selling better.
As long as we remain in a low lending rate environment, which makes vehicles more affordable, and crude oil stays near multi-year lows, keeping prices at the pump down, GM and its forward P/E of six and dividend yield of nearly 5% are probably going to remain quite the attraction.
Rising healthcare costs got your down? Let a healthcare real estate investment trust cheer you right up! HCP is a REIT that invests in and leases out buildings in the healthcare field, including hospitals, skilled nursing and long-term care facilities, life science and biotech research office buildings, and even senior housing.
Source: Flickr user Vic.
Think about this for a moment: we have an aging U.S. population that's living longer than ever, and healthcare spending is expected to reaccelerate to a growth rate of 5.8% per year between now and 2024. That represents a major money-making opportunity for all facets of the healthcare sector, from drug developers to senior housing businesses. And what better way to take advantage of this push for extra spending than to build a real estate portfolio filled with these assets?
Furthermore, the Federal Reserve's continued accommodative stance on interest rates appears poised to ease the pain of top dividend stocks like HCP. Although I believe it's a bad move for traders, as lending rates rise it's commonplace for income investors to abandon dividend-paying stocks in favor of safer growth prospects, such as CDs or bonds. With the Fed likely targeting only a 2% federal funds rate, and potentially taking years to get there, I doubt that high-yield REITs like HCP will be cast to the backburner anytime soon.
Consider HCP and its nearly 6% yield among your top dividend stocks to consider for October.
Another strong candidate to put extra money in your pocket is payroll processing provider Paychex (say that three times fast, I dare you!).
I suspect there are two big catalysts headed Paychex's way that could wind up benefiting its business in a big way. First, the U.S. economy has been on a six-year long rebound, resulting in the lowest unemployment rate (5.1% in August) since April 2008, when the U.S. could even claim a 5% unemployment rate. More working Americans, be it part-time or full-time, means more payrolls processed for Paychex. In the company's most recent quarterly report, it recorded an 8% year-over-year revenue jump and a 10% rise in EPS, so you could certainly suggest it's firing on all cylinders.
The other catalyst is that an eventual rising rate environment is going to be a nice benefit for payroll processing services like Paychex. The businesses that Paychex services often transfer the funds to cover employee paychecks days or weeks in advance of payday. Paychex doesn't just twiddle its thumbs, so to speak, with this cash -- it actively invests this lump sum in safe, short-term, fixed income investment tools and securities that allow it to boost its net income. Even if the Fed only boosts rates by 1.5% to 2% over the next three years, it could make a substantial difference in Paychex's interest-based investment income.
Currently yielding 3.6%, Paychex is a top dividend that I'd encourage you to consider for October.
The $15,978 Social Security bonus most retirees completely overlook
If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income. In fact, one MarketWatch reporter argues that if more Americans knew about this, the government would have to shell out an extra $10 billion annually. For example: one easy, 17-minute trick could pay you as much as $15,978 more... each year! Once you learn how to take advantage of all these loopholes, we think you could retire confidently with the peace of mind we're all after. Simply click here to discover how you can take advantage of these strategies.
The article Top Dividend Stocks to Buy in October originally appeared on Fool.com.
Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen nameTMFUltraLong, track every pick he makes under the screen nameTrackUltraLong, and check him out on Twitter, where he goes by the handle@TMFUltraLong.The Motley Fool recommends General Motors. Try any of our Foolish newsletter services free for 30 days . We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy .
Copyright © 1995 - 2015 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy .